CORT insider transaction filings
CORCEPT THERAPEUTICS INC — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-20. Screen CORT transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-20 | 4 | MAHONEY DAVID L — Director | Sale (S): 4,984 @ $117.47 · Sale (S): 91,167 @ $118.24 · Sale (S): 7,055 @ $118.88 · Sale (S): 400 @ $119.64 | EDGAR |
| 2026-08-18 | 4 | Robb Gary Charles — Chief Business Officer | Gift (G): 125 @ $0 · Sale (S): 10,000 @ $116.26 | EDGAR |
| 2026-08-18 | 4 | WILSON JAMES N — Director | Sale (S): 3,053 @ $110.49 · Sale (S): 4,668 @ $111.44 · Sale (S): 2,279 @ $112.64 | EDGAR |
| 2026-08-18 | 4 | Maduck Sean — See Remarks | Option exercise (M): 3,664 @ $8.27 · Sale (S): 3,664 @ $114.49 · Option exercise (M): 3,664 (derivative) @ $0 | EDGAR |
| 2026-08-14 | 4 | Robb Gary Charles — Chief Business Officer | Gift (G): 11,530 @ $0 · Gift (G): 3,000 @ $0 · Gift (G): 3,000 @ $0 | EDGAR |
| 2026-08-12 | 4 | Guyer William — Chief Development Officer | Option exercise (M): 16,300 @ $21.65 · Sale (S): 11,530 @ $113.18 · Sale (S): 4,770 @ $114.04 · Option exercise (M): 16,300 (derivative) @ $0 | EDGAR |
| 2026-08-12 | 4 | Maduck Sean — See Remarks | Option exercise (M): 1,031 @ $8.27 · Sale (S): 1,031 @ $114.52 · Option exercise (M): 1,031 (derivative) @ $0 | EDGAR |
| 2026-08-06 | 4 | Guyer William — Chief Development Officer | Option exercise (M): 3,700 @ $21.65 · Sale (S): 3,700 @ $113.12 · Option exercise (M): 3,700 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Maduck Sean — See Remarks | Option exercise (M): 20,305 @ $8.27 · Sale (S): 20,305 @ $114.70 · Option exercise (M): 20,305 (derivative) @ $0 | EDGAR |
| 2026-08-05 | 4 | Lyon Joseph Douglas — See Remarks | Sale (S): 1,540 @ $114.16 | EDGAR |
| 2026-08-03 | 4 | Mokari Atabak — Chief Financial Officer | Option exercise (M): 80,000 @ $23.06 · Sale (S): 4,200 @ $105.54 · Sale (S): 8,956 @ $106.96 · Sale (S): 400 @ $108.46 · Sale (S): 2,202 @ $110.03 · Sale (S): 600 @ $110.95 · +9 more | EDGAR |
| 2026-07-17 | 4 | WILSON JAMES N — Director | Sale (S): 1,079 @ $86.78 · Sale (S): 3,969 @ $87.74 · Sale (S): 2,974 @ $88.81 · Sale (S): 1,978 @ $89.49 | EDGAR |
| 2026-07-17 | 4 | Mokari Atabak — Chief Financial Officer | Option exercise (M): 15,833 @ $19.26 · Option exercise (M): 24,167 @ $23.06 · Sale (S): 7,919 @ $86.78 · Sale (S): 28,460 @ $87.89 · Sale (S): 3,520 @ $88.30 · Sale (S): 101 @ $89.43 · +2 more | EDGAR |
| 2026-07-08 | 4 | Robb Gary Charles — Chief Business Officer | Gift (G): 600 @ $0 | EDGAR |
| 2026-07-08 | 4 | Guyer William — Chief Development Officer | Option exercise (M): 20,000 @ $21.65 · Sale (S): 19,048 @ $93.11 · Sale (S): 952 @ $93.54 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-07-06 | 4 | Maduck Sean — See Remarks | Option exercise (M): 25,000 @ $8.27 · Sale (S): 11,024 @ $87.33 · Sale (S): 2,801 @ $88.51 · Sale (S): 11,175 @ $89.31 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | WILSON JAMES N — Director | Sale (S): 4,177 @ $82.69 · Sale (S): 5,823 @ $83.57 | EDGAR |
| 2026-06-18 | 4 | MAHONEY DAVID L — Director | Sale (S): 20,000 @ $84.53 | EDGAR |
| 2026-06-17 | 4 | Mokari Atabak — Chief Financial Officer | Option exercise (M): 40,000 @ $19.26 · Sale (S): 9,434 @ $80.02 · Sale (S): 11,081 @ $80.94 · Sale (S): 19,483 @ $81.81 · Sale (S): 2 @ $82.45 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Guyer William — Chief Development Officer | Option exercise (M): 20,000 @ $21.65 · Sale (S): 20,000 @ $70.60 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Lyon Joseph Douglas — See Remarks | Grant/award (A): 537 @ $70.44 · Grant/award (A): 537 @ $0 · Tax withholding (F): 269 @ $70.44 | EDGAR |
| 2026-06-03 | 4 | Guyer William — Chief Development Officer | Grant/award (A): 877 @ $70.44 · Grant/award (A): 877 @ $0 | EDGAR |
| 2026-06-03 | 4 | Maduck Sean — See Remarks | Option exercise (M): 25,000 @ $8.27 · Sale (S): 21,069 @ $70.11 · Sale (S): 3,931 @ $70.75 · Grant/award (A): 615 @ $70.44 · Grant/award (A): 615 @ $0 · Tax withholding (F): 452 @ $70.44 · +1 more | EDGAR |
| 2026-06-03 | 4 | Mokari Atabak — Chief Financial Officer | Option exercise (M): 40,000 @ $19.26 · Sale (S): 40,000 @ $70.00 · Grant/award (A): 634 @ $70.44 · Grant/award (A): 634 @ $0 · Tax withholding (F): 395 @ $70.44 · Option exercise (M): 40,000 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Robb Gary Charles — Chief Business Officer | Grant/award (A): 776 @ $70.44 · Grant/award (A): 776 @ $0 · Tax withholding (F): 358 @ $70.44 | EDGAR |
| 2026-06-02 | 4 | BELANOFF JOSEPH K — Chief Executive Officer, Director | Gift (G): 300,000 @ $0 · Gift (G): 150,000 @ $0 · Gift (G): 150,000 @ $0 · Sale (S): 12,837 @ $69.74 | EDGAR |
| 2026-05-29 | 4 | Lyon Joseph Douglas — See Remarks | Sale (S): 5,000 @ $65 | EDGAR |
| 2026-05-29 | 4 | Maduck Sean — See Remarks | Option exercise (M): 75,000 @ $8.27 · Sale (S): 54,575 @ $65.37 · Sale (S): 20,425 @ $66.16 · Option exercise (M): 75,000 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | WILSON JAMES N — Director | Gift (G): 892,056 @ $0 · Gift (G): 9,011 @ $0 · Gift (G): 9,011 @ $0 | EDGAR |
| 2026-05-26 | 4 | BAKER G LEONARD JR — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | Alton Gregg H — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | WILSON JAMES N — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | Swisher Daniel N JR — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | Murray Joshua M. — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | MAHONEY DAVID L — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2026-05-26 | 4 | Park Kimberly — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2026-05-15 | 4 | Robb Gary Charles — Chief Business Officer | Gift (G): 5,300 @ $0 · Gift (G): 1,000 @ $0 · Gift (G): 1,000 @ $0 | EDGAR |
| 2026-05-07 | 4 | Guyer William — Chief Development Officer | Option exercise (M): 20,000 @ $21.65 · Sale (S): 20,000 @ $51.83 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | BELANOFF JOSEPH K — Chief Executive Officer, Director | Sale (S): 40,000 @ $50.10 | EDGAR |
| 2026-04-24 | 4 | WILSON JAMES N — Director | Gift (G): 2,000 @ $0 | EDGAR |
| 2026-04-08 | 4 | Guyer William — Chief Development Officer | Option exercise (M): 20,000 @ $21.65 · Sale (S): 20,000 @ $40.97 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2026-04-08 | 4 | WILSON JAMES N — Director | Gift (G): 5,000 @ $0 | EDGAR |
| 2026-03-27 | 4 | BELANOFF JOSEPH K — Chief Executive Officer, Director | Sale (S): 26,198 @ $50.07 | EDGAR |
| 2026-03-24 | 4 | WILSON JAMES N — Director | Gift (G): 4,000 @ $0 | EDGAR |
| 2026-03-24 | 4 | Guyer William — Chief Development Officer | Option exercise (M): 11,767 @ $21.65 · Sale (S): 11,767 @ $36.01 · Option exercise (M): 11,767 (derivative) @ $0 | EDGAR |
| 2026-03-19 | 4 | BAKER G LEONARD JR — Director | Purchase (P): 75,782 @ $33.00 · Purchase (P): 24,218 @ $33.56 | EDGAR |
| 2026-03-17 | 4 | WILSON JAMES N — Director | Gift (G): 28,000 @ $0 | EDGAR |
| 2026-03-17 | 4 | MAHONEY DAVID L — Director | Option exercise (M): 30,000 @ $5.86 · Tax withholding (F): 5,469 @ $32.15 · Gift (G): 24,531 @ $0 · Other (J): 24,531 @ $0 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Guyer William — Chief Development Officer | Option exercise (M): 8,233 @ $21.65 · Sale (S): 8,233 @ $35.99 · Option exercise (M): 8,233 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Lyon Joseph Douglas — See Remarks | Grant/award (A): 398 @ $35.97 · Grant/award (A): 398 @ $0 · Tax withholding (F): 89 @ $35.97 | EDGAR |
Recent 8-K events — CORCEPT THERAPEUTICS INC
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-29 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-03 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-28 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-25 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-24 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-19 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-22 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-31 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CORT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →